The FDA is committed to addressing the nationwide disaster of opioid addiction on all fronts, with a substantial target lowering publicity to opioids and protecting against new addiction; supporting the therapy of These with opioid use disorder; fostering the development of novel agony procedure therapies and opioids far more resistant to abuse and… Read More